Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-02-06

Clinical Trial Update: Epiceram Versus Elidel for Treatment of Mild to Moderate Atopic Dermatitis [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial compares Epiceram with Elidel for treating mild to moderate atopic dermatitis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Elidel (pimecrolimus)
  • EpiCeram

Snippet

Sponsor: Ceragenix Pharmaceuticals | Conditions: Atopic Dermatitis | Phase 4 | Status: COMPLETED